Acute retinal necrosis: Difference between revisions

	Acute retinal necrosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Acute retinal necrosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Acute retinal necrosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Acute retinal necrosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Acute retinal necrosis
CDC on Acute retinal necrosis
Acute retinal necrosis in the news
Blogs on Acute retinal necrosis
Directions to Hospitals Treating Acute retinal necrosis
Risk calculators and risk factors for Acute retinal necrosis

VisualWikitext

Latest revision as of 20:16, 29 July 2020

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S.; Faizan Sheraz, M.D. [2]

Synonyms and keywords: Retinal necrosis syndrome; Acute retinal necrosis syndrome; Necrotizing herpetic retinitis; Bilateral acute retinal necrosis

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute retinal necrosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Treatment

Case Studies

Case #1

Source

American Academy of Ophthalmology

Template:WikiDoc Sources

@@ Line 1: / Line 1: @@
-{{Infobox disease
- | Name           = Acute retinal necrosis
- | Image          =
- | Caption        =
- | DiseasesDB     =
- | ICD10          =
- | ICD9           =
- | ICDO           =
- | OMIM           =
- | MedlinePlus    =
- | eMedicineSubj  = oph
- | eMedicineTopic = 377
- | MeshID         = D015882
-}}
 __NOTOC__
-{{SI}}
+{{Acute retinal necrosis}}
-{{CMG}}; {{AE}} {{Faizan}}.
-==Overview==
+'''For patient information click [[{{PAGENAME}} (patient information)|here]]'''
-'''Acute retinal necrosis''' is a type of [[retinitis]] which can be associated with viral infections.
-It was first characterized in 1971.<ref name="titleeMedicine - Acute Retinal Necrosis : Article by Andrew A Dahl, MD">{{cite web |url=http://www.emedicine.com/oph/topic377.htm |title=eMedicine - Acute Retinal Necrosis : Article by Andrew A Dahl, MD |accessdate=2008-02-05 |work=| archiveurl= http://web.archive.org/web/20080216011141/http://www.emedicine.com/oph/topic377.htm| archivedate= 16 February 2008 <!--DASHBot-->| deadurl= no}}</ref><ref>Urayama A, Yamada N, Sasaki T: Unilateral acute uveitis with retinal periarteritis and detachment. Jpn J Clin Ophthalmol 1971; 25: 607.</ref>
+{{CMG}} {{AE}} {{LRO}}; {{Faizan}}
-One study indicated an incidence of 1 per 1.6 to 2.0 million.<ref name="pmid17504853">{{cite journal |author=Muthiah MN, Michaelides M, Child CS, Mitchell SM |title=Acute retinal necrosis: a national population‐based study to assess the incidence, methods of diagnosis, treatment strategies and outcomes in the UK |journal=Br J Ophthalmol |volume=91 |issue=11 |pages=1452–5 |year=2007 |pmid=17504853 |doi=10.1136/bjo.2007.114884 |url=http://bjo.bmj.com/cgi/pmidlookup?view=long&pmid=17504853 |pmc=2095441}}</ref>
+{{SK}} Retinal necrosis syndrome; Acute retinal necrosis syndrome; Necrotizing herpetic retinitis; Bilateral acute retinal necrosis
-==Causes==
+==[[Acute retinal necrosis overview|Overview]]==
-The exact causes are not known, but [[varicella zoster virus]] is frequently implicated,<ref name="pmid17184841">{{cite journal |author=Lau CH, Missotten T, Salzmann J, Lightman SL |title=Acute retinal necrosis features, management, and outcomes |journal=Ophthalmology |volume=114 |issue=4 |pages=756–62 |year=2007 |pmid=17184841 |doi=10.1016/j.ophtha.2006.08.037 |url=http://linkinghub.elsevier.com/retrieve/pii/S0161-6420(06)01207-3}}</ref> and other [[herpesviridae|herpesviruses]] can be involved.<ref name="pmid17264500">{{cite journal |author=Kezuka T, Atherton SS |title=Acute retinal necrosis |journal=Chem Immunol Allergy |volume=92 |issue= |pages=244–53 |year=2007 |pmid=17264500 |doi=10.1159/000099275 |url=http://content.karger.com/produktedb/produkte.asp?doi=10.1159/000099275&typ=pdf |series=Chemical Immunology and Allergy |isbn=3-8055-8187-4}}</ref>
-==Treatment==
+==[[Acute retinal necrosis historical perspective|Historical Perspective]]==
-:*''' Empiric antimicrobial therapy'''
+==[[Acute retinal necrosis classification|Classification]]==
+==[[Acute retinal necrosis pathophysiology|Pathophysiology]]==
+==[[Acute retinal necrosis causes|Causes]]==
+==[[Differentiating Acute retinal necrosis from other diseases|Differentiating Acute retinal necrosis from other Diseases]]==
-::*Preferred regimen: [[Acyclovir]] 10 mg/kg IV q8h for 1-2 weeks followed by [[Acyclovir]] 400 mg PO bid for chronic maintenance
+==[[Acute retinal necrosis epidemiology and demographics|Epidemiology and Demographics]]==
-::*Alternative regimen (1): [[Acyclovir]] 10 mg/kg IV q8h for 1-2 weeks followed by [[Valacyclovir]] 1 g IV q8h for 6 weeks to several months followed by [[Acyclovir]] 400 mg PO bid for chronic maintenance
+==[[Acute retinal necrosis risk factors|Risk Factors]]==
-::*Alternative regimen (2), unresponsive: [[Foscarnet]] 1.2-2.4 mg/0.1 mL intravitreal injection 1-3 times per week {{and}} ([[Ganciclovir]] 5 mg/kg IV q12 for 2 weeks followed by 5 mg/kg q24h for 5-7 weeks {{or}} [[Foscarnet]] 60 mg/kg IV q8h for 2 weeks followed by 90-120 mg/kg IV q24h {{or}} [[Cidofovir]] 5 mg/kg IV for 2 weeks followed by 5 mg/kg IV q2weeks) followed by ([[Acyclovir]] 400 mg PO bid for chronic maintenance {{or}} [[Valganciclovir]] 900 mg PO qd for chronic maintenance)
-::*Note: [[Ganciclovir]] is administered for patients with suspected CMV acute retinal necrosis. Whereas [[Foscarnet]] is administered for patients who are not immunocompromised
+==[[Acute retinal necrosis screening|Screening]]==
-:*''' Pathogen-directed antimicrobial therapy'''
+==[[Acute retinal necrosis natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
-::*'''HSV or VZV'''
+==Diagnosis==
-:::*Preferred regimen: [[Acyclovir]] 10 mg/kg IV q8h for 1-2 weeks followed by [[Acyclovir]] 400 mg PO bid for chronic maintenance
+[[Acute retinal necrosis diagnostic criteria|Diagnostic Criteria]] | [[Acute retinal necrosis history and symptoms|History and Symptoms]] | [[Acute retinal necrosis physical examination|Physical Examination]] | [[Acute retinal necrosis laboratory findings|Laboratory Findings]] | [[Acute retinal necrosis electrocardiogram|Electrocardiogram]] | [[Acute retinal necrosis chest x ray|Chest X Ray]] | [[Acute retinal necrosis CT|CT]] | [[Acute retinal necrosis MRI|MRI]] | [[Acute retinal necrosis echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Acute retinal necrosis other imaging findings|Other Imaging Findings]] | [[Acute retinal necrosis other diagnostic studies|Other Diagnostic Studies]]
-:::*Alternative regimen: [[Acyclovir]] 10 mg/kg IV q8h for 1-2 weeks followed by [[Valacyclovir]] 1 g IV q8h for 6 weeks to several months followed by [[Acyclovir]] 400 mg PO bid for chronic maintenance
-::*''' Cytomegalovirus'''
+==Treatment==
-:::*Preferred regimen: [[Foscarnet]] 1.2-2.4 mg/0.1 mL intravitreal injection 1-3 times per week {{and}} [[Ganciclovir]] 5 mg/kg IV q12 for 2 weeks followed by 5 mg/kg q24h for 5-7 weeks followed by [[Valganciclovir]] 900 mg PO qd for chronic maintenance
-==See also==
+[[Acute retinal necrosis medical therapy|Medical Therapy]] | [[Acute retinal necrosis surgery|Surgery]] | [[Acute retinal necrosis primary prevention|Primary Prevention]] | [[Acute retinal necrosis secondary prevention|Secondary Prevention]] | [[Acute retinal necrosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Acute retinal necrosis future or investigational therapies|Future or Investigational Therapies]]
-* [[Cytomegalovirus retinitis]]
-* [[Progressive outer retinal necrosis]]
-==References==
+==Case Studies==
-{{reflist|2}}
+[[Acute retinal necrosis case study one|Case #1]]
-==External links==
+==Source==
-* http://www.iceh.org.uk/files/tsno8/text/18.htm
+[http://eyewiki.aao.org/Acute_retinal_necrosis American Academy of Ophthalmology]
-* http://www.eyepathologist.org/disease.asp?IDNUM=301330
+{{WikiDoc Help Menu}}
+{{WikiDoc Sources}}
-[[Category:Disorders of choroid and retina]]
+[[Category:Disease]]
-[[Category:Varicella zoster virus-associated diseases]]
+[[Category:Ophthalmology]]
+[[Category:Up-To-Date]]

Acute retinal necrosis: Difference between revisions

Latest revision as of 20:16, 29 July 2020

Diagnosis

Treatment

Case Studies

Source

Navigation menu